Literature DB >> 21796593

[Drug therapy of acute and chronic abdominal pain].

Konrad Streitberger1, Frank Stüber, Irène Kipfer Buchli, Ulrike M Stamer.   

Abstract

For drug therapy a differentiation of acute and chronic pain is essential. In emergency situations of acute abdominal pain a fast diagnosis is mandatory. Analgesia should be provided as soon as possible. The different groups of analgesics should be used according to their known effects, side effects and contraindications. Postoperative pain after abdominal surgery has to be considered as a special condition of acute abdominal pain. Main treatment options are non opioid analgesics and opioids. Opioids can be administered intravenously via patient controlled analgesia (PCA) devices. In major abdominal surgery neuroaxial analgesia, preferentially administered via an epidural catheter provides excellent pain relief with positive impact on gastrointestinal motility and patients' recovery. Because of difficulties to allocate chronic abdominal pain to a specific organ, causal treatment often turns out to be difficult. Peripheral and central sensitization, as well as an alteration of the endogenous pain modulation comes to the fore in these chronic pain conditions. Co-analgesics like anticonvulsants and antidepressants are utilized to reduce sensitization and improve the endogenous pain modulating system. Non drug approaches and alternative treatment options might be useful. In contrast, orally or transcutaneously administered opioids are the principal corner stone for the treatment of cancer pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796593     DOI: 10.1024/0040-5930/a000189

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  1 in total

1.  Efficacy and safety in ketamine-guided prehospital analgesia for abdominal pain.

Authors:  David Häske; Wolfgang Dorau; Niklas Heinemann; Fabian Eppler; Tobias Schopp; Benjamin Schempf
Journal:  Intern Emerg Med       Date:  2022-10-07       Impact factor: 5.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.